[Pharmacological properties and clinical efficacy of apixaban (Eliquis(®)]

Nihon Yakurigaku Zasshi. 2013 Nov;142(5):247-54. doi: 10.1254/fpj.142.247.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anticoagulants / administration & dosage*
  • Anticoagulants / pharmacology
  • Atrial Fibrillation / complications
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Factor Xa Inhibitors
  • Humans
  • Platelet Aggregation / drug effects
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects
  • Pyrazoles / pharmacology*
  • Pyridones / administration & dosage*
  • Pyridones / adverse effects
  • Pyridones / pharmacology*
  • Stroke / etiology
  • Stroke / prevention & control
  • Thrombin / metabolism
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Warfarin / administration & dosage
  • Warfarin / pharmacology

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Pyrazoles
  • Pyridones
  • apixaban
  • Warfarin
  • Thrombin